ont-10
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01978964)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ont-10
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02270372 | Phase 1 | Nov 1, 2014 | Cascadian Therapeutics Inc., Celldex Therapeutics |
| NCT01556789 | Phase 1 | Mar 1, 2013 | Cascadian Therapeutics Inc. |
| NCT01978964 | Phase 1 | Nov 1, 2012 | Cascadian Therapeutics Inc., Mary Crowley Cancer Center |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cascadian Therapeutics Inc. | For profit | 3 | 3 | 1 | 2012 |
| Celldex Therapeutics | For profit | 1 | 0 | 1 | 2014 |
| Mary Crowley Cancer Center | Academic/Hospital | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1